CEP20 and Miyoshi myopathy: Additionally, analysis of expression levels of both genes in a cohort of 654 MM patients treated within the GMMG HD4 and MM5 trials revealed that high expression levels of CEP20 and CEP97 were associated with poorer overall survival (Fig. 5C, Supplementary Fig. S4), reminiscent of our findings for the scaffold protein CEP350.